Alyeska Investment Group
IART icon

Alyeska Investment Group’s Integra LifeSciences IART Stock Holding History

Alyeska Investment Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,600
Closed -$369K – 451
2019
Q2 		$369K Buy
+6,600
New +$340K ﹤0.01% 413

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Alyeska Investment Group's IART Position: Q3 2019 in Review

Alyeska Investment Group sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 6,600 shares — an estimated $369K sold.

Alyeska Investment Group first reported a position in IART in Q2 2019 and held it in 1 quarter. The position peaked at $369K in Q2 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Alyeska Investment Group reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 6,600 Integra LifeSciences shares in Q3 2019, an estimated $369K.
  • Alyeska Investment Group first reported a position in Integra LifeSciences in Q2 2019 and held it in 1 quarter.
  • Alyeska Investment Group's Integra LifeSciences position peaked at $369K in Q2 2019.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.